bioLytical Donates 1200 HIV Testing Kits Across the United States to Support National HIV Testing Day
June 27 2024 - 9:00AM
bioLytical Laboratories Inc. ("bioLytical"), a global leader in
rapid diagnostic tests, proudly announces its donation of 1,200
INSTI® HIV-1/2 Antibody Tests to KFF’s Greater Than AIDS campaign
in support of National HIV Testing Day (NHTD) today, June 27. This
significant contribution aims to enhance access to HIV testing,
promote awareness, and encourage timely diagnosis and treatment,
ultimately helping to reduce the spread of HIV.
Increasing Test Access: A Crucial Step in Combating
HIV
In an effort to amplify the impact of National HIV Testing Day,
bioLytical is partnering with KFF to offer free testing events at
over 550 Walgreens countrywide. These events aim to raise awareness
about the importance of HIV testing and provide an accessible and
supportive environment for individuals to get tested. By working
together, bioLytical and KFF are fostering a collaborative approach
to public health, ensuring that testing is not only available but
also convenient and approachable for everyone.
By providing these 1,200 testing kits for NHTD, bioLytical is
committed to making HIV testing more available to those in need,
ensuring that more people can know their status and take proactive
steps toward managing their health.
Working Together to End HIV as a Public Health
Threat
"We are honoured to support National HIV Testing Day by
providing these essential testing kits," said David Weaver, VP of
Commercial at bioLytical. “We see this as a valuable partnership,
highlighting the power of working together to create more testing
opportunities. As a company dedicated to helping solve some of the
world’s most challenging health concerns, we understand the
importance of providing additional options for more people to know
their status. Together, we can make a meaningful impact and move
closer to ending HIV as a public health threat.”
This collaboration is a crucial step in eliminating the
traditional barriers that prevent people from accessing vital
health information and taking proactive measures to manage their
health and receive the care they need.
Ensuring equitable and regular access to HIV testing is vital in
the fight to end HIV as a public health threat, and early detection
through accessible testing not only helps reduce onward infections
but also connects individuals to necessary treatment and care.
The fight against HIV requires collective effort and unwavering
commitment. bioLytical's donation of 1,200 HIV testing kits is a
testament to our dedication to this cause. Through collaboration
with healthcare providers, community organizations, and public
health initiatives, America can make significant strides in
reducing HIV transmission and connecting people to life-saving
treatment and care.
About bioLytical Laboratories Inc.
bioLytical Laboratories Inc. is a privately owned Canadian
company focused on researching, developing, and commercializing
rapid medical diagnostics using its proprietary INSTI® technology
platform and its lateral flow line, iStatis. By delivering accurate
results in real-time, INSTI® and iStatis generate meaningful
outcomes for medical professionals, patients, and public health
organizations worldwide, and we are key partners in tackling some
of the world's most severe healthcare challenges. Please visit
www.biolytical.com, www.insti.com, and www.istatis.com for more
information.
Media Contact:
Stephanie Ritchie, Communications Specialist, bioLytical
press@biolytical.com
+1-778-238-9340